Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Contineum Therapeutics (CTNM) Assets Average (2024 - 2025)

Contineum Therapeutics has reported Assets Average over the past 2 years, most recently at $186.9 million for Q3 2025.

  • Quarterly results put Assets Average at $186.9 million for Q3 2025, down 14.55% from a year ago — trailing twelve months through Sep 2025 was $186.9 million (down 14.55% YoY), and the annual figure for FY2024 was $171.6 million, changed.
  • Assets Average for Q3 2025 was $186.9 million at Contineum Therapeutics, down from $190.6 million in the prior quarter.
  • Over the last five years, Assets Average for CTNM hit a ceiling of $218.7 million in Q3 2024 and a floor of $127.0 million in Q1 2024.